HealthMore in Health→
Macrophage Cell Therapy Shows Long-Term Promise in Advanced Cirrhosis
A clinical trial suggests macrophage-based cell therapy could meaningfully improve four-year transplant-free survival for patients with advanced cirrhosis, offering a potential alternative to liver transplantation for a病
Key Takeaways
- A MATCH clinical trial compared macrophage cell therapy with standard care in advanced cirrhosis.
- After four years, 70% of treated patients were alive without transplant versus 40% in the control group.
DE
DT Editorial Team··via medicalxpress.com